Trials / Sponsors / Alteogen, Inc.
Alteogen, Inc.
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Clinical Study of ALT-BB4 to Determine Tolerance, Safety and Pharmacokinetics in Healthy Volunteer Health, Subjective | Phase 1 | 2022-01-18 |
| Completed | Clinical Study of ALT-L9 to Determine Safety, Efficacy and Pharmacokinetics in Neovascular AMD Neovascular Age-related Macular Degeneration | Phase 1 | 2020-02-05 |
| Completed | Clinical Study of ALT-P7 to Determine Safety, Tolerability and Pharmacokinetics in Breast Cancer Patients HER2-positive Breast Cancer | Phase 1 | 2018-01-11 |
| Completed | A Comparing Study Between ALT02(Trastuzumab Biosimilar) and Herceptin® in Healthy Subjects Healthy | Phase 1 | 2016-02-09 |